The nuclear receptor peroxisome proliferator-activated receptor γ (PPARγ) is a central signal integrator in maintaining lipid and glucose homeostasis and is used as clinical target to treat diseases such as type 2 diabetes mellitus and the metabolic syndrome1,2. Here, PPARG is linked to diabetes mellitus.